 |
|
|
|
|
|
|
|
|
 Loading..
|
|
|
|
|
|
|
| Company Name |
BSE Code |
Date |
Purpose |
 IDream Film
|
504375 |
10-Dec-25 |
Softbpo Global Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/12/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform that a meeting of the Board of Directors of the Company is scheduled on Monday December 08 2025 inter alia to consider and if deemed appropriate approve raising of funds through issue of securities/equity shares by way of preferential issue on a private placement basis in accordance with SEBI (ICDR) Regulations 2018 and the Companies Act 2013 subject to necessary approvals including that of the shareholders. Further in terms of the Companys Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in securities has been closed with effect from December 03 2025 and shall remain closed till expiry of 48 hours after conclusion of the Board Meeting. This is for your information and records.
Softbpo Global Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/12/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, with reference to our earlier intimation dated December 03, 2025, regarding meeting of the Board of Directors of the Company to be held on Monday, the December 08, 2025, we hereby informed the Stock Exchange that the aforesaid meeting is rescheduled to be held on Wednesday, the December 10, 2025, inter alia, to consider and evaluate, and if deemed appropriate, approve raising of funds through issue of securities / equity shares of the Company by way of preferential issue on a private placement basis, in accordance with the applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to receipt of necessary statutory / regulatory approvals, including approval of the shareholders of the Company.
(As Per BSE Announcement Dated on:08.12.2025) |
| Fermenta Biotec.
|
506414 |
10-Dec-25 |
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/12/2025 ,inter alia, to consider and approve the proposal for raising of funds.
|
| Alps Industries
|
530715 |
10-Dec-25 |
Alps Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/12/2025 ,inter alia, to consider and approve Intimation of Board Meeting - Implementation of Resolution Plan as approved by the Hon'ble NCLT Prayagraj vide its order dated 04th November, 2025.
|
| Hilton Met.Forg.
|
532847 |
10-Dec-25 |
Hilton Metal Forging Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/12/2025 ,inter alia, to consider and approve 1. Right Issue Size, Issue Price, Right Entitlement Ratio and other matters incidental therewith and connected thereto the Right Issue of the Company and to consider, approve, adopt and take on record Letter of Offer ('LOF') and to fix the record date for determining eligible shareholders; 2.Any other business as may be considered necessary.
|
| Onelife Capital
|
533632 |
10-Dec-25 |
Onelife Capital Advisors Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/12/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 10th December 2025 through video conferencing/other audio-visual means inter alia to transact the following businesses; 1.To consider fund raising by way of an issuance of equity shares to its eligible equity shareholders on a rights basis (Rights issue) subject to receipt of necessary approvals from Regulatory Authorities 2. To transact other incidental and ancillary matters as may be decided by the board. |
|
1 2 3
|
|
|
|
|
|
|
|
|
|
|
|